Abstract

Background/aim We aimed to assess the association between retinal vascular caliber (RVC) scores and disease activity in rheumatoid arthritis (RA) patients.Materials and methods Forty-seven RA patients, 32 systemic lupus erythematosus (SLE) patients, and 45 healthy people were enrolled. RA and SLE patients were subdivided into groups according to C-reactive protein (CRP) levels. RA patients were also grouped according to Disease Activity Score-28 (DAS-28). Fundus photography was performed for all patients. RVC was summarized as the central retinal artery and vein equivalents (CRAE and CRVE).Results Mean CRVE for RA patients was 213.3 ± 17.8 µm compared with 209.2 ± 14.1 µm for SLE and 217.5 ± 26.2 µm for the control group (P = 0.17). RVC scores did not differ between the CRP-high and CRP-low groups. As the RA disease activity increased, the widening of CRVE became more prominent and statistically significant. When the DAS-28 > 5.1 (CRVE, 220.4 (211.8–246.5) µm) group and DAS-28 ≤ 3.2 (CRVE, 214.4 (172.4–242.3) µm) group were compared, statistical significance was more pronounced (P = 0.03) than when comparing the DAS-28 > 3.2 and DAS-28 ≤ 3.2 groups (P = 0.05). Conclusion CRVE, which reflects systemic inflammation and possibly increased cardiovascular risk, was significantly increased in active RA patients. The association between retinal venular widening and disease activity, regardless of CRP, may be a sign that RA-related inflammation may have systemic vascular effects even with normal levels of CRP.

Highlights

  • Cardiovascular diseases (CVDs) are the leading cause of death worldwide [1]

  • Mean central retinal venular equivalent (CRVE) for Rheumatoid arthritis (RA) patients was 213.3 ± 17.8 μm compared with 209.2 ± 14.1 μm for systemic lupus erythematosus (SLE) and 217.5 ± 26.2 μm for the control group (P = 0.17)

  • Three of the SLE patients had renal involvement in past, the glomerular filtration rate values of all patients were within the normal range at the time of the study and none of the patients had chronic renal disease

Read more

Summary

Introduction

Cardiovascular diseases (CVDs) are the leading cause of death worldwide [1]. Microvascular disease plays a role in the early development of CVDs and can be reversed. For this reason, strategies for improving microvascular health are a favorite subject for researchers [2,3]. Rheumatoid arthritis (RA) is known to be associated with endothelial dysfunction and a greater risk of cardiovascular (CV) morbidity and mortality [4,5,6]. The excess of CV morbidity and mortality in RA patients cannot be explained by traditional risk factors. There is much evidence that chronic inflammation and autoimmunity may cause this increased risk [2,4,7]

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.